You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-RUNX2 antibodySee all RUNX2 primary antibodies ...
  • Description
    Rabbit polyclonal to RUNX2
  • Specificityab23981 detects a band at 57 kDa corresponding to the size of the RUNX2 protein. It also detects additional bands at 37 kDa and 85 kDa, the identity of which is unknown.
  • Tested applicationsICC/IF, IHC-P, WB, Gel supershift assays more details
  • Species reactivity
    Reacts with: Rat, Dog, Human
    Predicted to work with: Mouse
  • Immunogen

    Synthetic peptide conjugated to KLH derived from within residues 300 - 400 of Human RUNX2.

    (Peptide available as ab26346.)

  • Positive controlIn Western Blot, ab23981 gave a positive signal in Saos2 and U20S whole cell lysates. In IF, the antibody gave a positive signal in U20S cells.

Properties

Applications

Our Abpromise guarantee covers the use of ab23981 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
ICC/IF ICC/IF: Use at an assay dependent concentration.
IHC-P IHC-P: Use at an assay dependent dilution. PubMed: 19092814
WB WB: Use a concentration of 1 µg/ml. Detects a band of approximately 60 kDa (predicted molecular weight: 57 kDa).Can be blocked with RUNX2 peptide (ab26346).
Gel supershift assays GSA: Use at an assay dependent dilution.

Target

  • FunctionTranscription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters (By similarity). Inhibits MYST4-dependent transcriptional activation.
  • Tissue specificitySpecifically expressed in osteoblasts.
  • Involvement in diseaseDefects in RUNX2 are the cause of cleidocranial dysplasia (CLCD) [MIM:119600]; also known as cleidocranial dysostosis (CCD). CLCD is an autosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies.
  • Sequence similaritiesContains 1 Runt domain.
  • DomainA proline/serine/threonine rich region at the C-terminus is necessary for transcriptional activation of target genes and contains the phosphorylation sites.
  • Post-translational
    modifications
    Phosphorylated; probably by MAP kinases (MAPK) (By similarity). Isoform 3 is phosphorylated on Ser-340.
  • Cellular localizationNucleus.
  • Target information above from: UniProt accession Q13950 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Acute myeloid leukemia 3 protein antibodyalpha subunit 1 antibodyAML3 antibody
      CBF alpha 1 antibodyCBF-alpha-1 antibodyCBFA1 antibodyCCD antibodyCCD1 antibodycleidocranial dysplasia 1 antibodyCore binding factor antibodyCore binding factor runt domain alpha subunit 1 antibodyCore binding factor subunit alpha 1 antibodycore-binding factor antibodyCore-binding factor subunit alpha-1 antibodyMGC120022 antibodyMGC120023 antibodyOncogene AML 3 antibodyOncogene AML-3 antibodyOSF 2 antibodyOSF-2 antibodyOSF2 antibodyOsteoblast specific transcription factor 2 antibodyOsteoblast-specific transcription factor 2 antibodyOTTHUMP00000016533 antibodyPEA2 alpha A antibodyPEA2-alpha A antibodyPEA2aA antibodyPEBP2 alpha A antibodyPEBP2-alpha A antibodyPEBP2A1 antibodyPEBP2A2 antibodyPEBP2aA antibodyPEBP2aA antibodyPEBP2aA1 antibodyPolyomavirus enhancer binding protein 2 alpha A subunit antibodyPolyomavirus enhancer-binding protein 2 alpha A subunit antibodyrunt domain antibodyRunt related transcription factor 2 antibodyrunt-related transcription factor 2 antibodyRUNX2 antibodyRUNX2_HUMAN antibodySL3 3 enhancer factor 1 alpha A subunit antibodySL3-3 enhancer factor 1 alpha A subunit antibodySL3/AKV core binding factor alpha A subunit antibodySL3/AKV core-binding factor alpha A subunit antibody
    see all

Anti-RUNX2 antibody images

  • ab23981 at a 1/1000 dilution staining RUNX2 in human U2-OS cells by Immunocytochemistry/ Immunofluorescence.

    Cells were fixed in paraformaldehyde and permeabilized using 0.1% Triton X-100. Samples were blocked using 2% serum. The secondary used was an Alexa Fluor® 488 conjugated chicken anti-mouse at a 1/1000 dilution.
  • All lanes : Anti-RUNX2 antibody (ab23981) at 1 µg/ml

    Lane 1 : Saos 2 (Human epithelial-like osteosarcoma cell line) Nuclear Extract
    Lane 2 : U2OS (Human osteosarcoma cell line) Whole Cell Lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (HRP) (ab97051) at 1/10000 dilution
    developed using the ECL technique

    Performed under reducing conditions.

    Predicted band size : 57 kDa
    Observed band size : 56,60 kDa (why is the actual band size different from the predicted?)
    Additional bands at : 40 kDa. We are unsure as to the identity of these extra bands.

    Exposure time : 12 minutes

References for Anti-RUNX2 antibody (ab23981)

This product has been referenced in:
  • Tang N  et al. Up-regulated osteogenic transcription factors during early response of human periodontal ligament stem cells to cyclic tensile strain. Arch Med Sci 8:422-30 (2012). WB ; Human . Read more (PubMed: 22851995) »
  • Martínez C  et al. Sonic hedgehog stimulates proliferation of human periodontal ligament stem cells. J Dent Res 90:483-8 (2011). Read more (PubMed: 21441223) »

See all 7 Publications for this product

Product Wall

Displaying 1 - 7 of 7 results for Abreviews and Q&A

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (U2OS)
Specification U2OS
Fixative Formaldehyde
Permeabilization Yes - NP40
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 3% · Temperature: 21°C
Username

Verified customer

Submitted Oct 08 2012

Thank you for confirming these details and for your cooperation. The details provided enable us to closely monitor the quality of our products.

I am sorry these products did not perform as stated on the datasheet and for the inconvenience this ...

Read More

Thank you for your inquiry.

We have a number of antibodies in our catalog that might be of interest to you. The following RUNX2 antibodies are tested and therefore covered by our 6 month guarantee in both paraffin embedded sections and mouse. (...

Read More
Application Immunocytochemistry
Sample Human Cultured Cells (primary smooth muscle cells)
Specification primary smooth muscle cells
Fixative Methanol
Permeabilization Yes - 0.5% NP40/PBS
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 3% · Temperature: 25°C
Username

Verified customer

Submitted Mar 21 2012

Application Western blot
Sample Dog Cell lysate - whole cell (Bone derived osteoblasts)
Loading amount 50 µg
Specification Bone derived osteoblasts
Gel Running Conditions Reduced Denaturing (10%)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
Username

Verified customer

Submitted Feb 04 2011

Abreviews
Application ChIP
Sample Human Cell lysate - whole cell (Mesenchymal stem cell)
Specification Mesenchymal stem cell
Type Cross-linking (X-ChIP)
Duration of cross-linking step: 8 minute(s) and 0 second(s)
Specification of the cross-linking agent: 1% formaldehyde
Detection step Real-time PCR
Positive control PCR on ChIP DNA with primers against anticipated RUNX2 target sequences containing OSE2 elements: RUNX2 promoter, BGLAP promoter
Negative control PCR with primers against sequences that do not contain OSE2 elements: GAPDH promoter, Satellite 2 sequence

No antibody control
Username

Verified customer

Submitted Nov 26 2010

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (U2-OS)
Specification U2-OS
Fixative Paraformaldehyde
Permeabilization Yes - 0.1% Triton-X-100/PBS
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 2% · Temperature: 20°C
Username

Verified customer

Submitted Jul 25 2008

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"